News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

CannLabs Announces Science Advisory Board Members


6/25/2014 11:02:01 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

DENVER, CO--(Marketwired - June 24, 2014) - Following its successful public launch, CannLabs, Inc., (OTCQB: SDSPD) announced members of its Science Advisory Board, Dr. Margaret Gedde, M.D., Ph.D. and Dr. Paul Matthews, Ph.D.

CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The board helps validate the company's scientific methodologies as it relates to cannabis testing and regularly meets with the management team to provide perspective on other related areas. The company expects to announce additional members to the Science Advisory Board over the coming months.

Dr. Margaret Gedde, M.D., Ph.D.
Dr. Gedde is a Stanford trained pathologist and award winning researcher who worked in the pharmaceutical industry for four years. She has operated a holistic, integrative practice since 2004.

Dr. Gedde has been focused on medical cannabis since 2009, and helps patients with chronic pain, nausea, seizures and other conditions while improving the quality of their lives. She is the founder of the Clinicians' Institute for Cannabis Medicine and medical director of Vibrant Health Clinic.

Dr. Paul Matthews, Ph.D.
Dr. Matthews has a Ph.D. in plant molecular biology and 20 years of research experience in both academia and industry. He currently is developing genomic strategies for applied evolution of medicinal crops. He is the author of more than 30 peer-reviewed publications, patents and invited book chapters.

Dr. Matthews has been president of the Hop Research Council and is the Vice Chairman of the National Clean Plant Network Hops.

ABOUT CANNLABS

CannLabs, Inc., is a solutions provider with intellectual property, proprietary cloud-based analytics and scientific methods to serve the cannabis industry. Through Carbon Bond Holdings Inc., CannLabs provides laboratories with the necessary business intelligence technology and other solutions required to serve the cannabis industry, and these include the first state-licensed laboratory in Denver, Colorado.

CannLabs enables growers, dispensaries and edible makers to implement best practices while furthering product advancements. In addition, the CannLabs website allows consumers to easily locate certified tested products to meet their specific needs.

CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The Company provides client education around safe cultivation, identifying contamination problems, consulting on legal cases and the reformulation of cannabis products, throughout the U.S. and Canada.

The Company plans to license their solutions to new labs and other cannabis companies in states and provinces as legislation and testing mandates for legalization are approved. This will allow the Company to further scale its data analytics and consulting business across a broader geographic area. In addition, the CannLabs team will focus on research and development which will further drive value for their customers and provide incremental revenue opportunity.

For more information visit www.cannlabs.com.

Safe Harbor Statement
All statements herein other than statements of historical facts are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Such statements are not guarantees of future performance and are subject to known and unknown risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements. Such factors include, but are not limited to, our ability to raise additional capital, our limited operating history and revenue, our ability to attract and retain qualified personnel, our ability to develop new services, market acceptance of our services, legislative, regulatory and competitive developments in our industry, general economic conditions, as well as other factors set forth in our filings with the SEC.


CONTACT:

Company
Robert Farrell
Vice President of Marketing
855-842-6936
robert.farrell@cannlabs.com
www.cannlabs.com

Investor Relations
Matt Hayden
Chairman
MZ North America
949-259-4986
matt.hayden@mzgroup.us
www.mzgroup.us

DENVER, CO--(Marketwired - June 24, 2014) - Following its successful public launch, CannLabs, Inc., (OTCQB: SDSPD) announced members of its Science Advisory Board, Dr. Margaret Gedde, M.D., Ph.D. and Dr. Paul Matthews, Ph.D.

CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The board helps validate the company's scientific methodologies as it relates to cannabis testing and regularly meets with the management team to provide perspective on other related areas. The company expects to announce additional members to the Science Advisory Board over the coming months.

Dr. Margaret Gedde, M.D., Ph.D.
Dr. Gedde is a Stanford trained pathologist and award winning researcher who worked in the pharmaceutical industry for four years. She has operated a holistic, integrative practice since 2004.

Dr. Gedde has been focused on medical cannabis since 2009, and helps patients with chronic pain, nausea, seizures and other conditions while improving the quality of their lives. She is the founder of the Clinicians' Institute for Cannabis Medicine and medical director of Vibrant Health Clinic.

Dr. Paul Matthews, Ph.D.
Dr. Matthews has a Ph.D. in plant molecular biology and 20 years of research experience in both academia and industry. He currently is developing genomic strategies for applied evolution of medicinal crops. He is the author of more than 30 peer-reviewed publications, patents and invited book chapters.

Dr. Matthews has been president of the Hop Research Council and is the Vice Chairman of the National Clean Plant Network Hops.

ABOUT CANNLABS

CannLabs, Inc., is a solutions provider with intellectual property, proprietary cloud-based analytics and scientific methods to serve the cannabis industry. Through Carbon Bond Holdings Inc., CannLabs provides laboratories with the necessary business intelligence technology and other solutions required to serve the cannabis industry, and these include the first state-licensed laboratory in Denver, Colorado.

CannLabs enables growers, dispensaries and edible makers to implement best practices while furthering product advancements. In addition, the CannLabs website allows consumers to easily locate certified tested products to meet their specific needs.

CannLabs has been at the forefront of educating the public, in addition to state and local governments as more states legalize marijuana for various uses. The Company provides client education around safe cultivation, identifying contamination problems, consulting on legal cases and the reformulation of cannabis products, throughout the U.S. and Canada.

The Company plans to license their solutions to new labs and other cannabis companies in states and provinces as legislation and testing mandates for legalization are approved. This will allow the Company to further scale its data analytics and consulting business across a broader geographic area. In addition, the CannLabs team will focus on research and development which will further drive value for their customers and provide incremental revenue opportunity.

For more information visit www.cannlabs.com.

Safe Harbor Statement
All statements herein other than statements of historical facts are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These statements are based upon our current expectations and speak only as of the date hereof. Such statements are not guarantees of future performance and are subject to known and unknown risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements. Such factors include, but are not limited to, our ability to raise additional capital, our limited operating history and revenue, our ability to attract and retain qualified personnel, our ability to develop new services, market acceptance of our services, legislative, regulatory and competitive developments in our industry, general economic conditions, as well as other factors set forth in our filings with the SEC.


CONTACT:

Company
Robert Farrell
Vice President of Marketing
855-842-6936
robert.farrell@cannlabs.com
www.cannlabs.com

Investor Relations
Matt Hayden
Chairman
MZ North America
949-259-4986
matt.hayden@mzgroup.us
www.mzgroup.us



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
CannLabs
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES